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Dysregulations of the central serotoninergic system have been implicated in several
psychopathologies, characterized by different susceptibility between males and females.
We took advantage of tryptophan hydroxylase 2 (TPH2) deficient rats, lacking serotonin
specifically in the brain, to investigate whether a vulnerable genotype can be associated
with alterations of neuronal plasticity from the early stage of maturation of the brain
until adulthood. We found a significant increase, in both gene and protein expression,
of the neurotrophin brain-derived neurotrophic factor (BDNF), in the prefrontal cortex
(PFC) of adult TPH2-deficient (TPH2−/−) male and female rats in comparison to wild
type (TPH2+/+) counterparts. Interestingly, a development-specific pattern was observed
during early postnatal life: whereas the increase in Bdnf expression, mainly driven by
the modulation of Bdnf isoform IV was clearly visible after weaning at postnatal day
(pnd) 30 in both sexes of TPH2−/− in comparison to TPH2+/+ rats, at early stages
(pnd1 and pnd10) Bdnf expression levels did not differ between the genotypes, or
even were downregulated in male TPH2−/− animals at pnd10. Moreover, to establish
if hyposerotonergia may influence the response to a challenging situation, we exposed
adult rats to an acute stress. Although the pattern of corticosterone release was similar
between the genotypes, neuronal activation in response to stress, quantified by the
expression of the immediate early genes activity regulated cytoskeleton associated
protein (Arc) and Fos Proto-Oncogene (cFos), was blunted in both sexes of animals
lacking brain serotonin. Interestingly, although upregulation of Bdnf mRNA levels after
stress was observed in both genotypes, it was less pronounced in TPH2−/− in
comparison to TPH2+/+ rats. In summary, our results demonstrated that serotonin
deficiency affects neuroplastic mechanisms following a specific temporal pattern and
influences the response to an acute stress.
Keywords: serotonin, TPH2, Bdnf, neuroplasticity, stress, immediate early gene
Abbreviations: 5-HT, 5-hydroxytryptamine; Arc, activity regulated cytoskeleton associated protein; ANOVA, analysis of
variance; BL, baseline; BDNF, brain-derived neurotrophic factor; CNS, central nervous systems; PLSD, Fisher’s Protected
Least Significant Difference; cFOS, Fos Proto-Oncogene; mBDNF, mature BDNF; pnd, postnatal day; PFC, prefrontal cortex;
RT-PCR, real-time polymerase chain reaction; SERT, serotonin transporter; SEM, standard error mean; TPH2, tryptophan
hydroxylase 2.
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INTRODUCTION
Serotonin 5-hydroxytryptamine (5-HT) was originally
discovered as cardiovascular hormone but has later gained
prominence as neurotransmitter or neuromodulator widely
distributed in the central nervous system (CNS) and peripheral
nervous systems. Nevertheless, by far the highest amounts of the
monoamine are produced in the intestine and released into the
blood stream, where it is taken up by platelets which transport it
through the circulation and release it at sites of their activation.
5-HT biosynthesis occurs from the essential aminoacid
tryptophan in two steps, and tryptophan hydroxylase 2 (TPH2)
is the rate-limiting enzyme in this process. As it has been
discovered in 2003 (Walther et al., 2003), 5-HT is produced
by two different enzymes, TPH1 and TPH2, in the gut and in
the brain, respectively. Since in adulthood it cannot pass the
blood-brain barrier, these two enzymes define two 5-HT systems
with independent regulation and different function. Although
in the adult brain 5-HT is produced only by serotonergic
neurons in raphe nuclei, during development there are other
sources of this monoamine, including maternal 5-HT, that is
actively transported through the placental brush border cells
via the serotonin transporter (SERT; Cool et al., 1990; Carrasco
et al., 2000; Kliman et al., 2018). Moreover, until postnatal day
(pnd) 12, the blood-brain barrier is immature (Ribatti et al.,
2006) and 5-HT, produced by TPH1 starting at embryonic
day 14 in rodents (Côté et al., 2007) can reach the brain.
In the early phases of embryonic and postnatal life, 5-HT
is a trophic factor that modulates not only cell proliferation,
migration and differentiation in the brain and in peripheral
tissues (Azmitia, 2001; Buznikov et al., 2001; Gaspar et al.,
2003) but also cell survival and synaptogenesis, through its
role in the connective organization of the CNS (Gaspar et al.,
2003).
Altered 5-HT concentration in the CNS have been implicated
in several psychopathologies (H. M., 1994; Brewerton, 1995;
Heninger, 1995), characterized by a different susceptibility
between males and females such as psychiatric disorders (Breslau
et al., 1997; Young and Korszun, 2010), as well as in an
altered antidepressant response and tolerance among males
and females (Kornstein et al., 2000). Moreover, serotonergic
pathways, serotonin synthesis (Nishizawa et al., 1997), the levels
of 5-HT metabolites (Gottfries et al., 1974), as well as the
expression and activity of different receptors and transporters
(Jovanovic et al., 2008) are modulated by sex. In this work we
investigate the impact of sex on susceptibility to alterations in
the serotonergic system using a new animal model deficient
in brain serotonin synthesis, TPH2-deficient (TPH2−/−) rats
(Kaplan et al., 2016).
Hence, we used male and female TPH2−/− rats to investigate
the influence of brain serotonin depletion on neuronal plasticity,
in particular on the brain-derived neurotrophic factor (BDNF)
from early life until adulthood. Indeed, it is well known that
there is a correlation between 5-HT and BDNF (Martinowich
and Lu, 2008), the main players in modulation of neurogenesis
and neuroplastic mechanisms across lifespan (Homberg et al.,
2014). Accordingly, we previously demonstrated that SERT
knockout rats showed impaired neuroplasticity starting from
the third week of life until adulthood (Calabrese et al., 2013).
Moreover, in order to evaluate if hyposerotonergia may alter the
response to a challenging condition, we exposed adult TPH2−/−
and wild type (TPH2+/+) rats to an acute stress focusing on
BDNF modulations, since it is known that there is a strong
relationship between acute stress response and neuroplasticity
(Calabrese et al., 2009) and that 5-HT may be involved in the
regulation of Bdnf expression during challenges (Foltran and
Diaz, 2016). All the molecular analyses were conducted in the
prefrontal cortex (PFC), a brain area involved in modulation
of mood disorders and strictly connected not only with the
neuromodulatory serotonin actions but also with BDNF (Duman
and Monteggia, 2006).
MATERIALS AND METHODS
Animals
Animals were kept under standardized conditions with an
artificial 12/12-h light/dark cycle (lights on at 6 a.m.), room
temperature of 22◦C, and approximately 80% humidity with
access to food (Ssniff, Soest, Germany) and water ad libitum.
Male and female TPH2-deficient (TPH2−/−) and wild type
(TPH2+/+) rats on the dark agouti background (Kaplan et al.,
2016) were used in the experiments. A cohort of adult
(12–14 weeks of age) TPH2+/+ and TPH2−/− male and female
animals (6–14 animals for each experimental group) was used
for the basal measurements. A second cohort of adult male and
female TPH2+/+ and TPH2−/− rats (4–7 per sex per condition,
see below ‘‘Stress Procedure’’ section) was used for the stress
experiment. For the developmental analysis male and female
rats were sacrificed at pnd 1, 10 and 30 (5–10 animals per
age, sex and genotype). All procedures were approved by the
ethical committee of the local government (LAGeSo, Berlin,
Germany).
Stress Procedure
Adult male and female TPH2+/+ and TPH2−/− rats were
exposed to acute restraint stress: rats were placed in an
air-accessible apparatus for 1 h. The size of the container was
similar to the size of the animal, which made the animal almost
immobile in it. Half of the stressed animals were sacrificed
immediately at the end of the stress session (stress0’), while
the other groups were sacrificed 60 min after the end of the
stress (stress60’). Unstressed animals served as control group
(baseline, BL). Animals were sacrificed by decapitation and trunk
blood was collected for the analysis of plasma corticosterone
levels.
Brain Tissue Collection
Animals were sacrificed by decapitation and brain regions of
interest were rapidly dissected, frozen on dry ice and stored at
−80◦C for the molecular analyses. Dissections were performed
according to the atlas of Paxinos and Watson (1998). In detail,
frontal lobe for pnd1-10-30 rats and PF for adult rats were
dissected from 2-mm-thick slices (PF defined as Cg1, Cg3 and
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IL subregions corresponding to plates 6–9 (approximate weight
8 mg)). The left hemisphere was taken for protein whereas the
right was taken for RNA.
RNA Preparation and Gene Expression
Analysis by Quantitative Real-Time PCR
Total RNA was isolated by a single step of guanidinium
isothiocyanate/phenol extraction using PureZol RNA
isolation reagent (Bio-Rad Laboratories, Italy) according
to the manufacturer’s instructions and quantified by
spectrophotometric analysis. Following total RNA extraction,
the samples were processed for real-time polymerase chain
reaction (RT-PCR) to assess total Bdnf, long 3′-UTR Bdnf and
the exons IV and VI, activity regulated cytoskeleton associated
protein (Arc) and Fos Proto-Oncogene (cFOS) mRNA levels.
An aliquot of each sample was treated with DNAse (Life
Technologies, Italy) to avoid DNA contamination. RNA was
analyzed by TaqMan qRT-PCR instrument (CFX384 real time
system, Bio-Rad Laboratories, Italy) using the iScriptTM one-step
RT-PCR kit for probes (Bio-Rad Laboratories, Italy). Samples
were run in 384 well formats in triplicate as multiplexed reactions
with a normalizing internal control (36B4). Primers and probes
(Tables 1A, B) were purchased from Eurofins MWG-Operon
(Germany) and Life Technologies (Italy). Thermal cycling was
initiated with an incubation at 50◦C for 10 min (RNA reverse
transcription) and then at 95◦C for 5 min (TaqMan polymerase
activation). After this initial step, 39 cycles of PCR were
performed. Each PCR cycle consisted of heating the samples at
95◦C for 10 s to enable the melting process and then for 30 s at
60◦C for the annealing and extension reactions. A comparative
cycle threshold method was used to calculate the relative target
gene expression (Livak and Schmittgen, 2001).
Protein Extraction and Western Blot
Analysis
Western blot analysis was used to investigate mature BDNF
in the crude synaptosomal fraction. Tissues were manually
homogenized using a glass-glass potter in a pH 7.4 cold
buffer containing 0.32 M sucrose, 0.1 mM EGTA, 1 mM
HEPES solution in the presence of a complete set of protease
(Roche) and phosphatase (Sigma-Aldrich) inhibitors. The total
homogenate was centrifuged at 2,500 rpm for 10 min at 4◦C.
The supernatant obtained was further centrifuged at 10,000 g
for 15 min at 4◦C to obtain the pellet corresponding to
the crude synaptosomal fraction which was re-suspended in
a buffer (20 mM HEPES, 0.1 mM dithiothreitol, 0.1 mM
EGTA) with protease and phosphatase inhibitors. Total protein
content was measured according to the Bradford Protein Assay
procedure (Bio-Rad Laboratories), using bovine serum albumin
as a calibration standard. Equal amounts of protein were run
under reducing conditions on the criterion TGX precast gels
(Bio-Rad Laboratories) and then electrophoretically transferred
onto nitrocellulose membranes (Bio-Rad Laboratories). The
blots were blocked with 10% nonfat dry milk and then incubated
with the primary antibodies (mature BDNF: 1:1,000 (Icosagen),
4◦ O/N; β-actin 1:10,000 (Sigma), 4◦C, O/N). Membranes were
then incubated for 1 h at room temperature with the appropriate
secondary antibody (mature BDNF: anti-mouse, 1:1,000, RT,
1 h; β-actin: anti-mouse1:10,000). Immunocomplexes were
visualized by chemiluminescence using the Western Lightning
Clarity ECL (Bio-Rad Laboratories) and the Chemidoc MP
imaging system (Bio-Rad Laboratories). BDNF expression was
quantified by the evaluation band densities, normalized to the β-
actin (ImageLab, Bio-Rad Laboratories).
Analysis of Plasma Corticosterone Levels
Samples of blood from each rat were collected in MiniCollect
K3EDTA (Greiner Bio-One GmbH, Frickenhausen,
Deutschland) tubes. Plasma was separated by centrifugation
for 10 min at 1,300 g, 4◦ and corticosterone was determined
by an enzyme-linked immunosorbent assay (ELISA) using
a commercial kit (IBL international, Hamburg, Germany)
according to the manufacturers’ instructions.
Statistical Analyses
All the statistical analyses were conducted by using ‘‘IBM SPSS
Statistics, version 24.’’ The effects of genotype and sex were
analyzed with the two-way analysis of variance (ANOVA) with
genotype and sex as independent factors. When appropriate,
differences between the individual groups were analyzed by
Fisher’s protected least significant difference (PLSD). The effects
of stress, genotype and sex in the acute stress experiments
were analyzed with three-way ANOVA with Fisher’s PLSD.
Significance for all tests was assumed for p < 0.05. Data are
presented as means ± standard error mean (SEM). For graphic
clarity, all qPCR and western blot results are normalized to male
TPH2+/+ values that are taken as 100%.
RESULTS
Analysis of Bdnf Transcripts and BDNF
Protein Levels in the PFC of TPH2−/− Male
and Female Adult Rats
We first investigated whether the mRNA expression of total
Bdnf was modulated by the lack of serotonin, in the PF of both
male and female adult rats. As shown in Figure 1A, we found a
significant effect of the genotype (F(1–52) = 10.232, p < 0.01) but
not of the sex and interaction genotype × sex. Post hoc analysis
revealed an increase of total Bdnf mRNA levels both in TPH2−/−
male rats (+23%, p< 0.05 vs. TPH2+/+) and in TPH2−/− female
rats (+25%, p < 0.05 vs. TPH2+/+). However, no difference was
found between the sexes for both genotypes.
To assess if the changes in total Bdnf mRNA were paralleled
by alterations in BDNF protein, we investigated the levels of
the mature form of BDNF (mBDNF) in crude synaptosomal
fraction (Figure 1B). Two-way ANOVA showed a significant
effect of the genotype (F(1–27) = 17.673, p < 0.001) with no
genotype × sex interaction. As revealed by post hoc analysis,
the levels of mBDNF were significantly increased in both male
(+78%, p < 0.05 vs. TPH2+/+/male) and female (+139%,
p < 0.01 vs. TPH2+/+/female) TPH2−/− rats in comparison to
the TPH2+/+ counterparts (Figure 1B).
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TABLE 1A | Sequences of forward and reverse primers and probes used in real-time polymerase chain reaction (RT-PCR) analysis and purchased from Eurofins
MWG-Operon (Germany; A) and from Life Technologies, which did not disclose the sequences (B).
(A) Forward and reverse primers and probes purchased from Eurofins MWG-Operon (Germany).
Gene Forward primer Reverse primer Probe
Arc GGTGGGTGGCTCTGAAGAAT ACTCCACCCAGTTCTTCACC GATCCAGAACCACATGAATGGG
cFos TCCTTACGGACTCCCCAC CTCCGTTTCTCTTCCTCTTCAG TGCTCTACTTTGCCCCTTCTGCC
Total Bdnf AAGTCTGCATTACATTCCTCGA GTTTTCTGGAGGGACAGTTTAT TGTGGTTTGTTGCCGTTGCCAAG
36b4 TTCCCACTGGCTGAGGT CGCAGCCGCTGC AAGGCCTTCCTGGCCGATCCATC
TABLE 1B | (B) Forward and reverse primers and probes purchased from Life
Technologies.
Gene Accession number Assay ID
Bdnf Long 3’UTR EF125675 Rn02531967_s1
Bdnf isoform IV EF125679 Rn01484927_m1
Bdnf isoform VI EF125680 Rn01484928_m1
Based on the enhancement of total Bdnf levels found in
TPH2−/− rats, we decided to evaluate if serotonin-deficiency
in the CNS differently affects the expression of major Bdnf
transcripts. In particular, we quantified the expression levels of
long 3’UTR Bdnf transcripts, and isoforms IV and VI to establish
their contribution to the observed modulation in total Bdnf.
Bdnf long 3’UTRwas significantly modulated by the genotype
(F(1–53) = 4.703, p < 0.05), with an up-regulation of Bdnf long
3’UTRmRNA levels specifically inmale TPH2−/− in comparison
to TPH2+/+ rats (+28%, p< 0.05 vs. TPH2+/+/male). Moreover,
the significant effect of the sex (F(1–53) = 5.884, p< 0.05) reflected
the increased expression of Bdnf long 3’UTR in female TPH2+/+
in comparison to male counterparts (+30%, p < 0.05 vs.
TPH2+/+/male; Figure 1C). On the contrary, two-way ANOVA
did not show a significant genotype× sex interaction.
Similarly to the results obtained for the total form of
the neurotrophin, we observed a significant effect of the
genotype (F(1–54) = 14.017, p < 0.05) for Bdnf isoform IV
(Figure 1D), with no effect of sex and genotype× sex interaction.
Accordingly, we found a significant upregulation of Bdnf IV
expression in TPH2−/− of both sexes (male: +39%, p < 0.01 vs.
TPH2+/+/male; female: +27%, p< 0.05 vs. TPH2+/+/female).
On the contrary, as shown in Figure 1E, we found a significant
genotype × sex interaction (F(1–53) = 4.580, p < 0.05) for Bdnf
isoform VI. Indeed, Bdnf VI increased only in male TPH2−/−
rats (+22%, p< 0.05 vs. TPH2+/+/male).
Analysis of Bdnf Transcripts in the Frontal
Lobe of TPH2−/− Male and Female Rats
During Postnatal Development
To evaluate the impact of serotonin deficiency during
development on Bdnf expression, we investigated its mRNA
levels in TPH2+/+ and TPH2−/− rats at different ages of life,
namely pnd 1, 10 and 30 (Figure 2).
In male rats, we found a significant effect of the age
(F(2–43) = 107.444, p < 0.001) that is reflected by a significant
increase of total Bdnf transcripts in both genotypes, at
pnd10 compared to pnd1 rats (TPH2+/+/pnd10: +1657%,
p < 0.001 vs. TPH2+/+/pnd1; TPH2−/−/pnd10: +1467%,
p < 0.01 vs. TPH2−/−/pnd1) but also at pnd30 compared
to pnd10 animals (TPH2+/+/pnd30: +59%, p < 0.001 vs.
TPH2+/+/pnd10; TPH2−/−/pnd30: +240%, p < 0.001 vs.
TPH2−/−/pnd10; Figure 2A). Moreover, we found a significant
age× genotype interaction (F(2–43) = 7.115, p< 0.01). Indeed, the
developmental profiles of the Bdnf expression differed between
the genotypes, with an equal expression at pnd1, decreased total
Bdnf mRNA levels in TPH2−/− at pnd10 (−43%, p < 0.01 vs.
TPH2+/+/pnd10), and a significant increase at pnd30 (+22%,
p< 0.05 vs. TPH2+/+/ pnd30).
Similarly, we observed a significant effect of the age
(F(2–45) = 297.514, p < 0.001) for Bdnf long 3’UTR transcripts
with an upregulation from pnd10 to pnd30 in both TPH2+/+
(TPH2+/+/pnd30: +1315%, p < 0.001 vs. TPH2+/+/pnd10)
and TPH2−/− rats (TPH2−/−/pnd30: +1355%, p < 0.001 vs.
TPH2−/−/pnd10; Figure 2B).
Moreover, we found a significant effect of age
(F(2–46) = 287.421, p < 0.001) for Bdnf isoform IV, with
an increase in both genotypes from pnd10 to pnd30
(TPH2+/+/pnd30: +940%, p < 0.001 vs. TPH2+/+/pnd10;
TPH2−/−/pnd30: +1587%, p < 0.001 vs. TPH2−/−/pnd10).
Furthermore, there was a significant effect of the genotype
(F(1–46) = 8.667, p < 0.01) and a significant genotype × age
interaction (F(2–46) = 10.602, p < 0.001) with an upregulation of
Bdnf isoform IV at pnd30 in TPH2−/− rats (+43%, p< 0.001 vs.
TPH2+/+/pnd30; Figure 2C).
Similarly, Bdnf isoform VI was significantly modulated by
the age (F(2–46) = 823.232, p < 0.001) with an increase both in
TPH2+/+ and TPH2−/− from pnd1 to pnd10 (TPH2+/+/pnd10:
+486, p < 0.01 vs. TPH2+/+/pnd1; TPH2−/−/pnd10: +473,
p < 0.05 vs. TPH2−/−/pnd1) and also from pnd10 to pnd30
(TPH2+/+/pnd30: +570%, p < 0.001 vs. TPH2+/+/pnd10;
TPH2−/−/pnd30: +1072%, p < 0.001 vs. TPH2−/−/pnd10).
Moreover, we found a significant effect of the genotype
(F(1–46) = 10.912, p < 0.01) and a significant genotype × age
interaction (F(2–46) = 19.039, p < 0.001) with an upregulation
of Bdnf isoform VI only at pnd30 in TPH2−/− in comparison
to TPH2+/+ rats of the same age (+30%, p < 0.001 vs.
TPH2+/+/pnd30; Figure 2D).
As shown in Figure 2E, in female rats, we found a significant
effect of the age (F(2–41) = 105.889, p < 0.001) for total Bdnf
mRNA levels with a significant increase among the three ages.
Actually, we observed an enhancement from pnd1 to pnd10 only
in TPH2−/− rats (TPH2−/−/pnd10: +1624%, p < 0.01 vs.
TPH2−/−/pnd1), while starting from pnd10, an upregulation
of total Bdnf mRNA levels was seen in both genotypes
(TPH2+/+/pnd30: +170%, p < 0.001 vs. TPH2+/+/pnd10;
TPH2−/−/pnd30: +241%, p < 0.001 vs. TPH2−/−/pnd10).
Moreover, we found a significant increase of total Bdnf in
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FIGURE 1 | Analysis of brain-derived neurotrophic factor (Bdnf ) transcripts mRNA levels (A,C,D,E) and mature BDNF protein levels (B) in the crude synaptosomal
fraction of prefrontal cortex (PFC) of tryptophan hydroxylase 2 (TPH2+/+) and TPH2−/− adult male and female rats. The data, expressed as % of TPH2+/+ male rats,
represent the mean ± standard error mean (SEM) of at least 14 independent determinations for the RNA and six for the western blot. ∗p < 0.05, ∗∗p < 0.01 vs.
TPH2+/+ of the same sex; $p < 0.05 vs. TPH2+/+/male (two-way analysis of variance (ANOVA) with Fisher’s protected least significant difference (PLSD).
TPH2−/− rats compared to TPH2+/+ (+64%, p < 0.001 vs.
TPH2+/+/ pnd30) only at pnd30, as supported by the significant
effect of the genotype (F(1–41) = 8,400, p < 0.01) and of the
interaction age× genotype (F(2–41) = 9.843, p< 0.001).
With respect to Bdnf long 3’UTR (Figure 2F), we observed
a significant effect of the age (F(2–43) = 292.426, p < 0.001)
with a robust upregulation at pnd30 compared to pnd10 in
both TPH2+/+ (TPH2+/+/pnd30: +1601%, p < 0.001 vs.
TPH2+/+/pnd10) and TPH2−/− (TPH2−/−/pnd30: +1210%,
p< 0.001 vs. TPH2−/−/pnd10), but we didn’t find any significant
interaction of age× genotype.
Similarly, Bdnf isoform IV was significantly modulated by
the age (F(2–43) = 217.038, p < 0.001), but not by the genotype
in young female rats. Accordingly, we observed an increase
in both genotypes from pnd10 to pnd30 (TPH2+/+/pnd30:
+1484%, p < 0.001 vs. TPH2+/+/pnd10; TPH2−/−/pnd30:
+1676%, p < 0.001 vs. TPH2−/−/pnd10). Furthermore, the lack
of serotonin at pnd30 induced an upregulation of Bdnf isoform
IV in comparison to TPH2+/+/pnd30 (+25%, p < 0.01 vs.
TPH2+/+/pnd30; Figure 2G).
In line with what was observed for Bdnf long 3’UTR
transcripts, Bdnf isoform VI was significantly modulated by
the age (F(2–42) = 535.298, p < 0.001) with the increase,
both in TPH2+/+ and TPH2−/−, from pnd10 to pnd30
(TPH2+/+/pnd30: +2105%, p < 0.001 vs. TPH2+/+/pnd10;
TPH2−/−/pnd30: +5705%, p < 0.001 vs. TPH2−/−/pnd10;
Figure 2H).
Analysis of Stress Responsiveness in
TPH2−/− Male and Female Adult Rats
In order to evaluate if the lack of serotonin influences the
response to an acute stress challenge, we exposed the animals to
1 h of restraint stress and sacrificed them immediately at the end
of the stress session (stress0’) or 1 h later (stress60’).
In male rats, plasma corticosterone levels were significantly
modulated by the acute stress (F(1–27) = 60.729, p < 0.001).
Indeed, we found a strong increase in corticosterone levels in
rats of both genotypes at stress0’ time point in comparison
to BL conditions (unstressed rats; TPH2+/+/stress0’: +99%,
p < 0.001 vs. TPH2+/+/BL; TPH2−/−/stress0’: +98%,
p < 0.001 vs. TPH2−/−/BL), while a significant decrease
was observed in the group of rats killed at stress60’ time
point compared to BL groups of the same genotype
(TPH2+/+/stress60’: −61%, p < 0.01 vs. TPH2+/+/BL;
TPH2−/−/stress60’: −54%, p < 0.05 vs. TPH2−/−/BL) as well
as to stress0’ groups (TPH2+/+/stress60’: −81%, p < 0.001 vs.
TPH2+/+/stress0’; TPH2−/−/stress60’: −77%, p < 0.001 vs.
TPH2−/−/stress0’; Figure 3A).
As shown in Figure 3B, female rats showed high
heterogeneity in corticosterone levels at BL and in response
to stress. Statistical analysis revealed significant modulation of
plasma corticosterone levels by acute stress only in TPH2−/−
rats (F(1–42) = 5.239, p < 0.05), with an upregulation of
corticosterone levels in stress0’ group compared to BL (+82%,
p < 0.05 vs. TPH2−/−/BL) and a decrease at stress60’ time
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FIGURE 2 | Developmental analysis of total Bdnf (A,E), Bdnf long 3’UTR (B,F), Bdnf isoform IV (C,G) and Bdnf isoform VI (D,H) mRNA levels in TPH2−/− male and
female rats at postnatal days (pnd) 1, 10 and 30. The data, expressed as fold change to TPH2+/+/pnd1, are the mean ± SEM of at least five independent
determinations. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. TPH2+/+ rats/same pnd (two-way ANOVA with Fisher’s PLSD).
FIGURE 3 | Analysis of corticosterone plasma levels (A,B) and activity regulated cytoskeleton associated protein (Arc: C) and Fos Proto-Oncogene (cFos: D) mRNA
levels in the PFC of TPH2+/+ and TPH2−/− adult male and female rats, exposed to an acute restraint stress. The corticosterone data represent the mean ± SEM of
at least four independent determinations. Gene expression data are expressed as mean % of TPH2+/+/baseline (BL) males ± SEM of at least four independent
determinations. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. BL/same genotype; #p < 0.05, ##p < 0.01; ###p < 0.001 vs. stress0’/same genotype (two-way ANOVA
with Fisher’s PLSD panel A,B; three-way ANOVA with Fisher’s PLSD panel C,D).
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point with respect to TPH2−/−/stress0’ (−50%, p < 0.05 vs.
TPH2−/−/stress0’).
Analysis of the Immediate Early Genes Arc
and cFos Following Stress
Since we previously demonstrated the implication of the
immediate early genes in the response to acute stress (Molteni
et al., 2008) and their modulation due to the deletion of the
SERT (Molteni et al., 2010), here, we measured two markers of
neuronal activation, Arc and cFos, in order to evaluate if the lack
of serotonin in the CNS influenced the response to the restraint
stress.
As shown in Figure 3C, three-way ANOVA did not reveal
a significant genotype × stress × sex interaction (F(2–101) =
1.668, p > 0.05) on the expression of Arc. Nevertheless,
we found a significant effect of the stress (F(2–101) = 5.692,
p < 0.01) with a genotype × stress interaction (F(2–101) =
7.181, p < 0.01). Accordingly, Arc mRNA levels were
increased by stress exposure only in the TPH2+/+ rats of
both sexes (TPH2+/+/stress60’/male: +97%, p < 0.001 vs.
TPH2+/+/BL/male; TPH2+/+/stress60’/male: +38%, p< 0.05 vs.
TPH2+/+/stress0’/male; TPH2+/+/stress0’/female: +54%, p <
0.01 vs. TPH2+/+/BL/female; TPH2+/+/stress60’/female: +42%,
p < 0.01 vs. TPH2+/+/BL/female). Interestingly, this stress-
mediated upregulation of Arc expression was completely blunted
in TPH2−/− rats.
Similarly, cFos expression was not significantly modulated
by genotype × stress × sex interaction (F(2–90) = 2.170,
p > 0.05). However, a significant effect of the stress
(F(2–90) = 20.596, p < 0.001) with a genotype × stress
interaction (F(2–90) = 19.110, p < 0.001) was observed.
Post hoc analysis revealed a strong increase in cFos mRNA
levels in TPH2+/+ male rats at both time points after stress
in comparison to BL (TPH2+/+/stress0’/male: +662%,
p < 0.001 vs. TPH2+/+/BL/male; TPH2+/+/stress60’/male:
+336%, p< 0.01 vs. TPH2+/+/BL/male). The upregulation of the
cFosmRNA levels peaked at stress0’ was markedly attenuated 1 h
later (−43%, p < 0.01 vs. TPH2+/+/stress0’/male), confirming
previously published data (Durchdewald et al., 2009). In
female, acute challenge induced an upregulation of cFos mRNA
levels in the TPH2+/+/stress0’ rats (+160%, p < 0.001 vs.
TPH2+/+/BL/female) and stress60’ group (+145%, p < 0.01 vs.
TPH2+/+/BL/female). This characteristic pattern was again not
observed in TPH2−/− female rats; moreover, 1 h after the stress
exposure we found a significant downregulation of cFos mRNA
levels in TPH2−/− rats (TPH2−/−/stress60’/female: −67%,
p < 0.01 vs. TPH2−/−/BL/female; TPH2−/−/stress60’/female:
−65%, p< 0.01 vs. TPH2−/−/ stress0’/female; Figure 3D).
Analysis of Bdnf Transcripts Following
Stress
The three-way ANOVA revealed no effect of the interaction
genotype × stress × sex (F(2–99) = 1.754, p > 0.05) on total Bdnf
FIGURE 4 | Analysis of total Bdnf, (A) Bdnf long 3’UTR, (B) Bdnf isoform IV and (C) Bdnf isoform VI (D) mRNA levels in the PFC of TPH2+/+ and TPH2−/− adult
male and female rats, exposed to an acute restraint stress. The data, expressed as % of TPH2+/+/BL males, represent the mean ± SEM of at least four independent
determinations. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. BL/same genotype; #p < 0.05, ##p < 0.01; ###p < 0.001 vs. stress0’/same genotype, $p < 0.05 vs.
TPH2+/+ /BL/male (three-way ANOVA with Fisher’s PLSD).
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gene expression (Figure 4A). However, we found a significant
effect of stress (F(2–99) = 112.032, p < 0.001). Accordingly,
total Bdnf was increased in both TPH2+/+ and TPH2−/− male
rats exposed to the acute stress and sacrificed at time point
stress0’ (TPH2+/+/Stress0’: +87%, p < 0.001 vs. TPH2+/+/BL;
TPH2−/−/Stress0’: +51%, p< 0.01 vs. TPH2−/−/BL) and at time
60’ (TPH2+/+/stress60’: +127%, p < 0.001 vs. TPH2+/+/BL;
TPH2−/−/Stress60’: +82%, p< 0.001 vs. TPH2−/−/BL).
In the female rats, the exposure to stress increased the
expression of total Bdnf, at both time points, in TPH2+/+
(TPH2+/+/stress0’: +146%, p < 0.001 vs. TPH2+/+/BL;
TPH2+/+/stress60’: +203%, p < 0.001 vs. TPH2+/+/BL) as
well as in TPH2−/− (TPH2−/−/stress0’: +51%, p < 0.01 vs.
TPH2−/−/BL; TPH2−/−/stress60’: +88%, p < 0.001 vs.
TPH2−/−/BL). Moreover, TPH2+/+stressed rats sacrificed
1 h after the stress exposure had higher mRNA levels compared
to the stress0’ groups (TPH2+/+/stress60’: +23%, p < 0.01 vs.
TPH2+/+/stress0’).
Furthermore, the significant genotype × stress interaction
(F(2–98) = 6.490, p < 0.01) indicates that the upregulation found
in TPH2+/+ was higher than the one observed in TPH2−/− rats.
Bdnf long 3’UTRmRNA levels (Figure 4B) were significantly
modulated by the interaction genotype × stress × sex
(F(2–101) = 3.203, p < 0.05). In particular, we found a significant
genotype × sex interaction (F(2–101) = 7.205, p < 0.01)
reflecting an upregulation of Bdnf long 3’UTR expression
in female TPH2+/+/BL compared to the male counterpart
(TPH2+/+/BL: +30%, p < 0.05 vs. TPH2+/+/BL). Moreover,
the significant effect of stress (F(2–101) = 109.926, p < 0.001)
indicated that Bdnf long 3’UTR was increased after the acute
challenge in male (TPH2+/+/stress0’/male: +112%, p < 0.001
vs. TPH2+/+/BL/male; TPH2+/+/stress60’/male: +161%,
p< 0.001 vs. TPH2+/+/BL/male; TPH2−/−/stress0’/male: +46%,
p < 0.01 vs. TPH2−/−/BL/male; TPH2−/−/stress60’/male:
+165%, p < 0.001 vs. TPH2−/−/BL/male) and in
female (TPH2+/+/stress0’/female: +73%, p < 0.001 vs.
TPH2+/+/BL/female; TPH2+/+/stress60’/female: +88%,
p < 0.001 vs. TPH2+/+/BL/female; TPH2−/−/stress0’/female:
+31%, p < 0.05 vs. TPH2−/−/BL/female;
TPH2−/−/stress60’/female: +46%, p < 0.001 vs.
TPH2−/−/BL/female), independently from the genotype.
Moreover, in male rats the up-regulation observed 1 h after
the stress exposure was significantly higher than the effect found
at time 0’ in both genotype (TPH2+/+/stress60’/male: +23%,
p < 0.001 vs. TPH2+/+/stress0’/male; TPH2−/−/stress60’/male:
81%, p< 0.001 vs. TPH2−/−/stress0’/male).
Finally, the significant genotype × stress interaction
(F(2–101) = 4,368, p < 0.05) indicates that the increase in
expression of Bdnf long 3’UTR due to stress exposure was more
robust in TPH2+/+ than in TPH2−/− rats.
Analysis of Bdnf isoform IV mRNA levels (Figure 4C)
revealed no effect of the genotype × stress × sex
interaction (F(2–101) = 0.094, p > 0.05), but a significant
effect of stress (F(2–101) = 66.292, p < 0.001). In male,
Bdnf isoform IV expression was upregulated by stress in
TPH2+/+ rats (TPH2+/+/stress0’/male: +88%, p < 0.001 vs.
TPH2+/+/BL/male; TPH2+/+/stress60’/male: +141%,
p < 0.001 vs. TPH2+/+/BL/male) with a further increase
from stress point 0’ to 60’ (TPH2+/+/stress60’/male:
+28%, p < 0.05 vs. TPH2+/+/stress0’/male) and in
TPH2−/− (TPH2−/−/stress0’/male: +37%, p < 0.01 vs.
TPH2−/−/BL/male; TPH2−/−/stress60’’/male: +41%,
p < 0.01 vs. TPH2−/−/BL/male). Moreover, Bdnf IV was
increased in unstressed TPH2−/− in comparison to TPH2+/+
rats (TPH2−/−/BL/male: +39%, p< 0.01 vs. TPH2+/+/BL/male).
In female, exposure to the acute stress increased
the Bdnf isoform IV mRNA levels in both genotypes
(TPH2+/+/stress0’/female: +98%, p < 0.001 vs.
TPH2+/+/BL/female; TPH2+/+/stress60’/female: +152%,
p < 0.001 vs. TPH2+/+/BL/female; TPH2+/+/stress60’/female:
+27%, p < 0.05 vs. TPH2+/+/stress0’/female;
TPH2−/−/stress0’/female: +39%, p < 0.05 vs.
TPH2−/−/BL/female; TPH2−/−/stress60’/female: +46%,
p < 0.01 vs. TPH2−/−/BL/female). Similar to total Bdnf and
Bdnf long 3’UTR, the significant genotype × stress interaction
(F(2–101) = 11.065, p < 0.001) was also observed for the Bdnf
isoform IV, suggesting a different response to the challenging
situation in the two genotypes in terms of magnitude of the
effect.
Similarly, Bdnf isoform VI mRNA levels (Figure 4D) were
not affected by the genotype × stress × sex interaction
(F(2–100) = 1.741, p> 0.05). However, the significant effect of the
genotype (F(2–100) = 10.338, p< 0.01) supports the slightly higher
mRNA levels found in unstressed male TPH2−/− compared
to unstressed TPH2+/+ male rats (TPH2−/−/BL/male: +22%,
p< 0.05 vs. TPH2+/+/BL/male).
Moreover, in females, isoform VI expression
was downregulated specifically in TPH2+/+ rats
(TPH2+/+/stress0’/female: −32%, p < 0.05 vs.
TPH2+/+/BL/female; TPH2+/+/stress60’/female: −26%,
p< 0.05 vs. TPH2+/+/BL/female), while its levels were increased
in TPH2−/− stressed rats sacrificed 1 h after the stress exposure
in comparison to the animals of the same genotype killed
immediately after the acute stress (TPH2+/+/stress60’/female:
+45%, p< 0.05 vs. TPH2−/−/stress0’/female).
DISCUSSION
The results of the present study highlight that the deletion of
Tph2 profoundly affects neuroplastic mechanisms from the first
stage of life until adulthood and influences the response to an
acute stress.
We found a significant increase of total Bdnf mRNA levels
in both adult TPH2−/− male and female rats. Interestingly, the
contribution of different Bdnf isoforms to this increase is sex-
specific: in male TPH2−/− rats, it is due to enhancement of all
Bdnf transcripts investigated, while in females only the isoform
IV is upregulated.
These results are in line with our previous data obtained
in a rat model with increased extracellular 5-HT levels,
SERT-deficient rats (Molteni et al., 2010; Calabrese et al., 2013).
While hyperserotonergia induced by SERT-deletion (Homberg
et al., 2007; Olivier et al., 2008) impairs neuronal plasticity in
the PFC and hippocampus by downregulation of Bdnf, serotonin
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depletion in the adult CNS has an opposite effect, confirming the
strict dependence of Bdnf expression on serotonergic status.
These effects were mirrored, at translational level, by an
upregulation of the mature form of BDNF protein levels in
the crude synaptosomal fraction in both male and female
TPH2−/− rats. The enhancement of the protective form of the
neurotrophin, that regulates synaptic connections and plasticity
(Martinowich et al., 2007) may be indicative for an increase
in the pool of the neurotrophin ready for the release (Poo,
2001; Lau et al., 2010). This suggests a potential compensatory
mechanism in the brain to deal with the absence of the trophic
contribution of serotonin, confirming data previously obtained
in PFC (Kronenberg et al., 2016) and hippocampus (Migliarini
et al., 2013) of TPH2-deficient mice.
Furthermore, it’s well known that ontogenesis is a critical
period for brain adaptability and plasticity. Several lines
of evidence support the fundamental role of 5-HT during
neurodevelopment (Lauder, 1993; Gaspar et al., 2003) as well as
that BDNF is a crucial molecule in promoting CNS growth and in
the establishment of neural circuitry including the serotoninergic
system (Mamounas et al., 1995). Accordingly, we observed a
stepwise increase in Bdnf expression from pnd1 to pnd30 in
wild type animals as previously demonstrated (Calabrese et al.,
2013). Although a similar profile was observed in TPH2−/−
rats, the comparison between the two genotypes revealed a
significant increase in total Bdnf mRNA levels in both male
and female TPH2−/− rats at pnd30. In males, this effect
was paralleled by an upregulation of Bdnf isoform IV and
VI, while in females this effect was, again, restricted to the
specific effect on the expression of the isoform IV. However,
no differences between genotypes at earlier time points (at birth
and at pnd10), or even downregulation in Bdnf expression
levels in TPH2−/− in comparison to TPH2+/+ pnd10 male
rats were observed, suggesting that peripheral sources may
compensate for the lack of central 5-HT synthesis during
the early postnatal periods of life. Indeed, the blood brain
barrier is not fully functional before pnd12 (Ribatti et al.,
2006) and 5-HT from the placenta at embryonic stages (Cool
et al., 1990; Carrasco et al., 2000) and from the peripheral
blood after birth may easily enter the brain. Accordingly,
Vitalis et al. (2007) demonstrated that the embryonic transient
5-HT depletion did not modify cortical BDNF levels until
PND21 in pups. In summary, these results suggest that the
activation of trophic mechanisms set in motion to compensate
the serotonin synthesis deficiency in the CNS became more
evident starting from pnd30, when there is no more supply of
5-HT from alternative sources, such as placenta and peripheral
blood.
Moreover, the different regulation of Bdnf isoforms we
found in females in comparison to males may be due to the
fact that different transcripts may have different subcellular
localization (Chiaruttini et al., 2008) and are controlled by
specific intracellular pathways (Aid et al., 2007).
Among these, sex hormones are known to contribute to
BDNFmodulations (Chan and Ye, 2017), in line with the finding
that estrogens can induce Bdnf expression by activating their
receptors and may modify the neurotrophin activity through
methylation of the Bdnf promoter IV and V in the hippocampus
(Moreno-Piovano et al., 2014). Moreover, sex steroids influence
serotonergic neurotransmission (Dalla et al., 2005; Kokras et al.,
2009). Indeed, for example it has been demonstrated that
androgens facilitate the 5-HT binding to its transporter SERT,
while estrogens seem to delay it (Kranz et al., 2015). Due to
the limited information available on the functional role of each
Bdnf transcript, it is not feasible to draw clear-cut conclusions
on the consequences exerted by differences in isoform expression
between male and female.
Seeing that, in basal condition, 5-HT deficiency was in some
way compensated by neuroplastic mechanisms and considering
the well-established relationship between the serotonergic system
and the stress reactivity (Chen and Miller, 2012; Homberg
et al., 2014) we then tested if the lack of central serotonin
affects the ability to cope with more dynamic conditions. So, we
exposed adult rats to 1 h of restraint stress and we sacrificed
them immediately at the end of the stress session or 1 h
later. We observed that corticosterone release was differently
modulated by stress in wild type males and females and it was
affected by lack of 5-HT in a sex specific manner. Indeed, as
expected from the literature (Adzic et al., 2009; Molteni et al.,
2009) stress exposure induced a strong release of corticosterone
immediately after the restraint stress in TPH2+/+ male rats
and a significant decrease 1 h later, while in females this
pattern was not so pronounced and was statistically significant
only in TPH2−/−, but not in TPH2+/+ rats. Corticosterone
levels in females are highly influenced by the estrus cycle
(Atkinson andWaddell, 1997) and by the stress (Figueiredo et al.,
2002). Since females used in our study were not synchronized,
high variability in the corticosterone levels in female rats of
both genotypes might originate from different estrus cycle
stages.
Furthermore, the implication of neuronal activation in
response to acute stress can be evaluated by the expression of
immediate early genes (Ons et al., 2004; Molteni et al., 2008), in
order to assess a different outcome to the acute restraint stress
exposure driven by 5-HT deficiency, we measured two markers
of neuronal activation, Arc and cFos. As expected, in both males
and female wild type rats we observed a clear stress response, with
the slow increase inArc expression during and 1 h after stress and
quick upregulation at stress0 and downregulation 1 h later in cFos
expression, confirming previously published data (Durchdewald
et al., 2009). Interestingly in both males and females, the lack
of 5-HT in the CNS influenced the response to the challenging
condition by preventing the upregulation of both the immediate
early genes mRNA levels found in TPH2+/+ rats. Seen that Arc
mediates the translation between neuronal activation-induced
changes into sustained structural and functional modification
at synaptic levels (Alberi et al., 2011), the lack of activation
observed in TPH2−/− rats may reflect an incorrect translation
of the stimulus into a more stable outcome.
Moreover, we have previously shown that hyperserotonergia,
evoked by the lack of SERT, has an opposite effect on the stress-
induced neuronal activation, leading to a more pronounced
upregulation of Arc in SERT-deficient rats in comparison to
wild types (Molteni et al., 2008). So, these opposite responses
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in the neuronal activation of PFC induced by acute stress in
hyper- (SERT-deficient) and hyposerotonergic (TPH2-deficient)
rats further support an important role of 5-HT in stress response.
Accordingly, it was recently shown that the 5-HT2 receptor
antagonist ketanserin also blocks Arc induction in the PFC
in response to a stress paradigm (Benekareddy et al., 2011).
Remarkably, this serotonin effect on neuronal activation seems to
be completely independent from the classical stress response via
the hypothalamus-pituitary adrenal axis which is hardly affected
by the absence of serotonin.
Finally, we found that, despite the increased levels of BDNF
observed in TPH2−/−, rats, this compensatory mechanism was
not enough to restore the normal ability to react to the acute
stress challenge, probably because of the complexity of the system
and circuit involved that may be BDNF-independent. Even if
Bdnf transcripts were upregulated in both genotypes in response
to stress, the effects found in TPH2+/+ were stronger than those
induced in the TPH2−/− rats. The fact that BDNF is upregulated
by stress in the PFC even in the absence of serotonin, while the
immediate early genes are not, suggests distinct stress-modulated
neural circuits whereby one is serotonergic, and another is 5-HT
independent.
Taken together our findings suggest that 5-HT deficiency in
the brain modulates neuroplasticity probably to compensate for
the lack of trophic support provided by serotonin starting after
weaning until adulthood. Nevertheless, in response to a stressful
condition the system is not able to properly respond by setting in
motion the strategies to cope with an acute challenge.
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